Anaergia Reports Positive Adjusted EBITDA¹ and Strong Revenue Growth in Fiscal 2025
Fourth Quarter Revenue Increased 111% and Gross Profit Expanded 79% Year-over-Year
Fourth Quarter and Full Year 2025 Highlights
-
Fourth quarter revenue of
$71.7 million , an increase of 111% over prior year fourth quarter -
Full year 2025 revenue of
$180.2 million , an increase of 61% over prior year -
Fourth quarter gross profit of
$16.1 million , an increase of 79% over the prior year fourth quarter -
Full year gross profit of
$46.8 million , an increase of 82% over the prior year -
Fourth quarter positive Adjusted EBITDA1 of
$4.2 million , an increase of 166% or$10.5 million , compared to a prior year fourth quarter loss of$(6.3) million -
Full year positive Adjusted EBITDA1 of
$0.6 million , an increase of 102% or$27.5 million , compared to a prior year loss of$(26.9) million -
Year-end 2025 Revenue Backlog increased 149% to
$257 million compared to the prior year-end
Management Commentary
“We are pleased to report that
“Revenue more than doubled in the fourth quarter of 2025 on a year-over-year basis, driving a significant lift in profitability and underscoring our leadership in the global biogas sector. In addition, we reduced our Selling, General and Administrative (SG&A) expenses both quarterly and annually, while our Revenue Backlog grew 149% year‑over‑year to
“Anaergia’s management team has remained disciplined, executing a comprehensive turnaround plan to streamline operations and rightsize the business. Through relentless focus on efficiency and long-term value creation, these efforts have successfully driven the company to achieve positive Adjusted EBITDA not only in the last two quarters of 2025, but also positive Adjusted EBITDA for the full year 2025. 2025 was a substantial turnaround year, and I would like to recognize our employees for their extraordinary performance in delivering this significant improvement,” Onn added.
Financial Highlights:
-
Revenue increased by 111% to
$71.7 million in Q4 2025from$34.1 million in Q4 2024. For Fiscal 2025, Revenue increased by 61% to$180.2 million from$111.6 million in Fiscal 2024. These increases were primarily driven by higher sales inItaly andNorth America . -
Gross Profit increased 79% to
$16.1 million in Q4 2025from$9.0 million in Q4 2024. For Fiscal 2025, Gross Profit increased by 82% to$46.8 million from$25.6 million in Fiscal 2024. These increases were mainly driven by our Capital Sales segment. -
Adjusted EBITDA
1 improved 166% to positive
$4.2 million in Q4 2025 compared to negative$6.3 million in Q4 2024. For Fiscal 2025, Adjusted EBITDA improved 102% to positive$0.6 million compared to negative$26.9 million in Fiscal 2024. These improvements in Adjusted EBITDA were primarily driven by increases in Revenues and Gross Profits, and by lower SG&A expenses.
|
Three months ended: |
|||
|
|
|
|
% Change |
|
(In millions of Canadian dollars, except %) |
|
|
|
|
Revenue |
71.7 |
34.1 |
111% |
|
Gross profit |
16.1 |
9.0 |
79% |
|
Gross profit % |
22.5% |
26.4% |
-4 percentage points |
|
Income (loss) from operations |
1.4 |
(7.2) |
119% |
|
Net income (loss) |
11.4 |
(15.4) |
174% |
|
Adjusted EBITDA1 |
4.2 |
(6.3) |
166% |
|
Twelve months ended: |
|||
|
|
|
|
% Change |
|
(In millions of Canadian dollars except %) |
|
|
|
|
Revenue |
180.2 |
111.6 |
61% |
|
Gross profit |
46.8 |
25.6 |
82% |
|
Gross profit % |
26.0% |
23.0% |
+3 percentage points |
|
Loss from operations |
(7.8) |
(40.0) |
81% |
|
Net loss |
(4.5) |
(55.9) |
92% |
|
Adjusted EBITDA1 |
0.6 |
(26.9) |
102% |
|
Statement of |
|
|||
|
Financial Position |
|
|
||
|
(In millions of Canadian dollars) |
|
|
||
|
Total Assets |
237.9 |
233.3 |
||
|
Total Liabilities |
182.4 |
180.1 |
||
|
Equity |
55.5 |
53.2 |
||
For a more detailed discussion of Anaergia’s results for the three-month and twelve-month periods ended
NON-GAAP MEASURES
This press release makes reference to certain non-GAAP measures. These non-GAAP measures are not recognized measures under IFRS® Accounting Standards as issued by the
Definitions of non-GAAP measures and industry metrics used in this press release are provided below.
“Adjusted EBITDA” is defined as net earnings before finance costs, taxes and depreciation and amortization adjusted for our normalized proportionate interest in our Build-Own-Operate assets and one-time or non-recurring items, stock-based compensation expense, asset impairment charges and write downs, gains and losses for equity-accounted investees, gain or loss on equity method adjustment, significant one-time provisions, foreign exchange gains or losses, restructuring costs,
“EBITDA” is defined as net income [loss] before finance costs, taxes and depreciation and amortization.
“Revenue Backlog” is defined as the balance of unrecognized, undiscounted, consolidated revenues from signed contracts in our Capital Sales and operation and maintenance services (“O&M Services”) segments. For our Capital Sales contracts, we have modeled only projects that have been contracted. For our O&M Services segment, while most of our in-hand contracts are 5-15 years in tenure, we have conservatively modeled for only 3 years of contracted revenue. See “Reconciliation of Non-IFRS Measures” below for a reconciliation of the foregoing non-IFRS measures to their most directly comparable measures calculated in accordance with IFRS.
Conference Call and Webcast Details
A conference call to review the Company’s financial results will take place at
To listen to the webcast live: https://events.q4inc.com/attendee/838906175
For analysts and shareholders Q&A registration: https://events.q4inc.com/analyst/838906175?pwd=35iQ0lRR
The webcast will be archived and available in the Investor Relations section of our website following the call.
About
For further information please see: www.anaergia.com
Forward-Looking Statements
This press release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may relate to future plans, expectations and intentions, results, levels of activity, performance, goals or achievements, other future events or developments and may include, without limitation, information regarding our financial position, business strategy, growth strategy, budgets, operations, financial results, taxes, plans and objectives. Particularly, information regarding our future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as “may”, “will”, “would”, “should”, “could”, “expects”, “plans”, “intends”, “estimate”, “believes”, “likely”, “potential”, “continue”, or “future” or the negative or other variations of these words or other comparable words or phrases. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances. Forward-looking statements in this press release include, among other things, statements relating to financial condition and results of operations; Company’s strategic transition to a capital-light model; and statements regarding the Company’s Revenue Backlog and potential future sales.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that we considered appropriate and reasonable as of the date such statements were made. It is also subject to known and unknown risks, uncertainties, assumptions and other factors that may cause our actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the risk factors described in the Company’s annual information form and management’s discussion and analysis for the year ended
Reconciliation of Non-GAAP Measures
(In thousands of Canadian dollars)
|
Three months ended: |
|
|
||
|
(In thousands of Canadian dollars) |
|
|
||
|
Net income (loss) |
11,361 |
(15,416) |
||
|
Finance costs, net |
1,203 |
1,969 |
||
|
Depreciation and amortization |
2,468 |
1,616 |
||
|
Income tax expense (recovery) |
(11,101) |
6,923 |
||
|
EBITDA 1 |
3,931 |
(4,908) |
||
|
Share based compensation expense (recovery) |
310 |
(1,634) |
||
|
Asset Impairment loss |
- |
352 |
||
|
Other (gains) losses |
(610) |
726 |
||
|
Severance costs |
- |
589 |
||
|
Foreign exchange (gain) loss |
534 |
(1,436) |
||
|
Adjusted EBITDA 1 |
4,165 |
(6,311) |
||
|
Twelve months ended: |
|
|
||
|
(In thousands of Canadian dollars) |
|
|
||
|
Net income (loss) |
(4,475) |
(55,864) |
||
|
Finance costs, net |
4,749 |
5,493 |
||
|
Depreciation and amortization |
6,756 |
5,650 |
||
|
Income tax expense (recovery) |
(10,413) |
6,465 |
||
|
EBITDA 1 |
(3,383) |
(38,256) |
||
|
Share based compensation expense (recovery) |
1,629 |
2,174 |
||
|
|
- |
6,244 |
||
|
Asset Impairment loss |
- |
1,939 |
||
|
Losses related to equity-accounted investees |
- |
1,062 |
||
|
Other (gains) losses |
271 |
(1,388) |
||
|
RIBF income tax credit transaction cost |
- |
2,416 |
||
|
Severance costs |
- |
965 |
||
|
Foreign exchange (gain) loss |
2,052 |
(2,048) |
||
|
Adjusted EBITDA 1 |
569 |
(26,892) |
| ___________________ |
| 1 “EBITDA,” “Adjusted EBITDA,” and “Revenue Backlog” are non-GAAP measures. See “Non-GAAP Measures” |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260325947483/en/
For media and/or investor relations please contact: IR@Anaergia.com
Source: